Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gadducci

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Gynecologic Oncology|May 1, 1996
Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancerA Gadducci, R Marrai, U Baicchi, et al.
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|July 1, 1986
[Rational bases of surgery in the therapeutic strategy for ovarian cancer]V Facchini, A Gadducci, B Del Bravo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 13, 2003
Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) studyE Sartori, B Laface, A Gadducci, et al.
Gynecologic Oncology|February 1, 1992
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosisA Gadducci, M Ferdeghini, C Prontera, et al.
Gynecologic Oncology|July 1, 1995
Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian studyA Gadducci, P Zola, F Landoni, et al.
British Journal of Obstetrics and Gynaecology|August 1, 1987
Carcinoma developing in bladder exstrophy. Case reportV Facchini, A Gadducci, L Colombi, et al.
European Journal of Gynaecological Oncology|January 1, 1990
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinomaA Gadducci, M Ferdeghini, C Prontera, et al.
European Journal of Gynaecological Oncology|January 1, 1986
Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancerP Fioretti, A Gadducci, M Ferdeghini, et al.
The Journal of Nuclear Medicine and Allied Sciences|January 1, 1989
The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary dataA Gadducci, M Ferdeghini, T Ceccarini, et al.
Gynecologic Oncology|June 1, 1994
Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with ovarian carcinomaA Gadducci, U Baicchi, R Marrai, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Gynecologic Oncology|May 1, 1996
Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancerA Gadducci, R Marrai, U Baicchi, et al.
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|July 1, 1986
[Rational bases of surgery in the therapeutic strategy for ovarian cancer]V Facchini, A Gadducci, B Del Bravo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 13, 2003
Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) studyE Sartori, B Laface, A Gadducci, et al.
Gynecologic Oncology|February 1, 1992
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosisA Gadducci, M Ferdeghini, C Prontera, et al.
Gynecologic Oncology|July 1, 1995
Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian studyA Gadducci, P Zola, F Landoni, et al.
British Journal of Obstetrics and Gynaecology|August 1, 1987
Carcinoma developing in bladder exstrophy. Case reportV Facchini, A Gadducci, L Colombi, et al.
European Journal of Gynaecological Oncology|January 1, 1990
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinomaA Gadducci, M Ferdeghini, C Prontera, et al.
European Journal of Gynaecological Oncology|January 1, 1986
Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancerP Fioretti, A Gadducci, M Ferdeghini, et al.
The Journal of Nuclear Medicine and Allied Sciences|January 1, 1989
The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary dataA Gadducci, M Ferdeghini, T Ceccarini, et al.
Gynecologic Oncology|June 1, 1994
Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with ovarian carcinomaA Gadducci, U Baicchi, R Marrai, et al.
Pageof 18